Viyash Scientific · NSE: VIYASH · BSE: 512529
Q4 FY25 results · Jan–Mar 2025
Viyash Scientific reported revenue from operations of ₹401.70 crore (up 11.2% from Q4 FY24) and net profit of ₹10.38 crore (up 714.8% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 401.70 | 361.20 | +11.2% | 390.81 | +2.8% |
| Other income | 1.66 | 4.00 | −58.5% | 5.84 | −71.6% |
| Total income | 403.36 | 365.19 | +10.5% | 396.65 | +1.7% |
| Profit before tax | 16.31 | 2.64 | +518.7% | 8.10 | +101.4% |
| Net profit for the period | 10.38 | 1.27 | +714.8% | 6.48 | +60.2% |
| Attributable to shareholders of the company | 9.32 | (0.91) | Turned profit | 3.44 | +170.9% |
| EPS, basic (₹) | 0.37 | (0.04) | not comparable | 0.14 | +168.1% |
| Net margin (%) | 2.6 | 0.4 | 1.7 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 42.33 | 36.77 | +15.1% | 36.27 | +16.7% |
| Other income | 12.27 | 12.97 | −5.4% | 11.88 | +3.3% |
| Total income | 54.60 | 49.75 | +9.8% | 48.15 | +13.4% |
| Profit before tax | 5.91 | 4.10 | +44.1% | 3.68 | +60.6% |
| Net profit for the period | 4.23 | 3.76 | +12.4% | 2.81 | +50.5% |
| EPS, basic (₹) | 0.17 | 0.15 | +13.3% | 0.11 | +54.5% |
| Net margin (%) | 10.0 | 10.2 | 7.7 |
Consolidated
- Filed with BSE
- 20 May 2025, 16:37 IST
- Board meeting
- 20 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 20 May 2025, 16:37 IST
- Board meeting
- 20 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE